COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
Trial ID or NCT#
NCT03809078
Status
Purpose
The objective of the study is to evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in patients with suspected prostate cancer.
Official Title
A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Andrei Iagaru
Radiologist
Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center
Pejman Ghanouni, MD, PhD
Radiologist
Associate Professor of Radiology (General Radiology) at the Stanford University Medical Center
Geoffrey Sonn
Urologic oncologist,
Urologist,
Urologic specialist,
Genitourinary specialist
Assistant Professor of Urology and, by courtesy, of Radiology at the Stanford University Medical Center
Contact us to find out if this trial is right for you.
CONTACT
Brittney Williams
(650) 736-3688
View on ClinicalTrials.gov